SCHEMBL4756908

SCHEMBL4756908

CC(C)S(=O)(=O)c1cnc(NC(=O)c2cc(O)cc(Cl)c2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.40
STAT3 P40763 3/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CDK5 Q00535 1/20 0.39
GRM4 Q14833 3/20 0.39
STIM1 Q13586 1/20 0.39
ORAI1 Q96D31 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
KDR P35968 1/20 0.36
HSD17B1 P14061 1/20 0.36
LMNA P02545 1/20 0.36
HCAR1 Q9BXC0 1/20 0.35
MAPT P10636 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13055695 0.82 STIM1 (0.41) FFAR2STAT3GRM4STIM1ORAI1
SCHEMBL10114276 0.79 RAB9A (0.60) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL4756601 0.79 KCNMA1 (0.53) FFAR2STAT3GRM4
SCHEMBL4756954 0.78 FFAR2 (0.46) FFAR2CCNE1CDK2CDK5GRM4
SCHEMBL4757018 0.77 GCK (0.45) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL13055688 0.76 CCNE1 (0.45) STAT3CCNE1CDK2CDK5STIM1
SCHEMBL4757122 0.76 MEN1 (0.41) CCNE1CDK2CDK5GRM4MEN1
SCHEMBL13951715 0.75 STAT3 (0.43) STAT3STIM1ORAI1MEN1KMT2A
SCHEMBL5835385 0.73 CDK2 (0.67) STAT3CCNE1CDK2CDK5STIM1
SCHEMBL4756621 0.72 KCNMA1 (0.45) FFAR2STAT3GRM4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC FFAR2 4045/4885STAT3 63/4885CCNE1 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.